Clinical trial for Acute Coronary Syndromes
Official title Oregano and Basil Leaves and Coronary Artery Disease
ClinicalTrials.gov ID: NCT07123181
What this study is testing
- What it's testing
- The study wants to see whether increasing polyphenols from oregano and basil changes blood inflammation and cholesterol levels, and raises polyphenol levels in urine.
- Who it's for
- Adults who have recently experienced unstable angina (a type of heart problem).
- What's involved
- Participants will regularly eat oregano and basil leaves and provide blood and urine samples so researchers can measure inflammation, cholesterol, and polyphenol levels.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 30 to 75
You may be able to join if
- Patients diagnosed with unstable angina
You likely can't join if
- Patients diagnosed with STEMI
- Patients undergoing coronary artery bypass grafting
- Liver cirrhosis and advanced chronic kidney disease (CKD 5)
- Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid...
- Pregnancy or breastfeeding
The study team makes the final eligibility decision.
Where it is enrolling
- Tehran, Tehran Province, Iran
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 30 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Tehran, Tehran Province, Iran. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.